PubRank

Eben L Rosenthal

Author PubWeight™ 83.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma. Mol Imaging Biol 2013 1.67
2 Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2011 1.62
3 Pretreatment, preoperative swallowing exercises may improve dysphagia quality of life. Laryngoscope 2006 1.59
4 Stereomicroscopic fluorescence imaging of head and neck cancer xenografts targeting CD147. Cancer Biol Ther 2008 1.57
5 Robotic-assisted surgery for primary or recurrent oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2010 1.52
6 Dynasplint for the management of trismus after treatment of upper aerodigestive tract cancer: a retrospective study. Ear Nose Throat J 2011 1.45
7 Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model. Head Neck 2008 1.42
8 Utility of CT surveillance for primary site recurrence of squamous cell carcinoma of the head and neck. Head Neck 2010 1.39
9 Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Arch Otolaryngol Head Neck Surg 2007 1.33
10 Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Ann Surg Oncol 2012 1.30
11 Functional outcomes after transoral robotic surgery for head and neck cancer. Otolaryngol Head Neck Surg 2009 1.29
12 The role of free tissue transfer in the reconstruction of massive neglected skin cancers of the head and neck. Arch Facial Plast Surg 2003 1.17
13 Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. BMC Cancer 2006 1.16
14 Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment. Cancer Biol Ther 2007 1.16
15 Free tissue transfer to manage salvage laryngectomy defects after organ preservation failure. Laryngoscope 2007 1.16
16 Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer. Clin Cancer Res 2009 1.16
17 Transoral robotic-assisted surgery for head and neck squamous cell carcinoma: one- and 2-year survival analysis. Arch Otolaryngol Head Neck Surg 2010 1.10
18 Assessment and incidence of salivary leak following laryngectomy. Laryngoscope 2012 1.10
19 Disruption of the AKT pathway inhibits metastasis in an orthotopic model of head and neck squamous cell carcinoma. Laryngoscope 2011 1.09
20 IND-directed safety and biodistribution study of intravenously injected cetuximab-IRDye800 in cynomolgus macaques. Mol Imaging Biol 2015 1.08
21 Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. Laryngoscope 2013 1.04
22 Assessment of indocyanine green-labeled cetuximab to detect xenografted head and neck cancer cell lines. Otolaryngol Head Neck Surg 2007 1.00
23 Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice. Clin Exp Metastasis 2004 0.98
24 Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice. Otolaryngol Head Neck Surg 2013 0.97
25 Outcomes of salvage surgery with free flap reconstruction for recurrent oral and oropharyngeal cancer. Laryngoscope 2010 0.97
26 (18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts. Mol Imaging Biol 2012 0.96
27 Incidence and outcomes of stricture formation postlaryngectomy. Otolaryngol Head Neck Surg 2011 0.95
28 Expandable tracheal stenting for benign disease: worth the complications? Ann Otol Rhinol Laryngol 2006 0.94
29 Closure of post-laryngectomy pharyngocutaneous fistulae. Head Neck Oncol 2011 0.94
30 Optical imaging predicts tumor response to anti-EGFR therapy. Cancer Biol Ther 2010 0.93
31 Outcomes following temporal bone resection. Laryngoscope 2010 0.93
32 EGFR expression in advanced head and neck cutaneous squamous cell carcinoma. Head Neck 2011 0.93
33 Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma. Cancer Biol Ther 2013 0.92
34 Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer. Arch Otolaryngol Head Neck Surg 2008 0.92
35 Free flap reconstruction of lateral mandibular defects: indications and outcomes. Otolaryngol Head Neck Surg 2011 0.91
36 Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis. J Oral Pathol Med 2014 0.91
37 Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells. Mol Cancer Res 2011 0.91
38 Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo model. Anticancer Drugs 2010 0.91
39 Robot-assisted surgery for upper aerodigestive tract neoplasms. Arch Otolaryngol Head Neck Surg 2009 0.90
40 Transoral robotic surgery for oropharyngeal and tongue cancer in the United States. Laryngoscope 2014 0.90
41 CD147 and AGR2 expression promote cellular proliferation and metastasis of head and neck squamous cell carcinoma. Exp Cell Res 2012 0.90
42 Primary versus delayed tracheoesophageal puncture for laryngopharyngectomy with free flap reconstruction. Laryngoscope 2011 0.90
43 Zygomatic-maxillary buttress reconstruction of midface defects with the osteocutaneous radial forearm free flap. Head Neck 2008 0.90
44 Outcomes in head and neck reconstruction by surgical site and donor site. Laryngoscope 2013 0.90
45 Influence of social support on health-related quality of life outcomes in head and neck cancer. Head Neck 2007 0.90
46 Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy. Anticancer Drugs 2011 0.89
47 Functional outcomes of fibula and osteocutaneous forearm free flap reconstruction for segmental mandibular defects. Laryngoscope 2010 0.89
48 Management of the N0 neck in recurrent laryngeal squamous cell carcinoma. Laryngoscope 2010 0.88
49 Current strategies in reconstruction of maxillectomy defects. Arch Otolaryngol Head Neck Surg 2011 0.88
50 Outcomes of static and dynamic facial nerve repair in head and neck cancer. Laryngoscope 2010 0.88
51 Molecular targeting of ultrasonographic contrast agent for detection of head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2012 0.88
52 Closure of laryngectomy defects in the age of chemoradiation therapy. Head Neck 2011 0.87
53 Assessment of tissue autofluorescence and reflectance for oral cavity cancer screening. Otolaryngol Head Neck Surg 2011 0.87
54 Validation of ultrasonography to evaluate murine orthotopic oral cavity tumors. ORL J Otorhinolaryngol Relat Spec 2006 0.87
55 Fistula analysis after radial forearm free flap reconstruction of hypopharyngeal defects. Laryngoscope 2008 0.85
56 Free flap reconstruction of self-inflicted submental gunshot wounds. Craniomaxillofac Trauma Reconstr 2011 0.85
57 Antibody-based imaging strategies for cancer. Cancer Metastasis Rev 2014 0.84
58 EMMPRIN expression is required for response to bevacizumab therapy in HNSCC xenografts. Cancer Lett 2008 0.82
59 Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck. Int J Oncol 2007 0.82
60 Harmonic Scalpel versus electrocautery and surgical clips in head and neck free-flap harvesting. Ear Nose Throat J 2014 0.82
61 The ulnar fasciocutaneous free flap in head and neck reconstruction. Laryngoscope 2002 0.82
62 A comparison of negative-pressure dressings versus Bolster and splinting of the radial forearm donor site. Otolaryngol Head Neck Surg 2005 0.82
63 A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma. Oral Oncol 2013 0.82
64 Fluorescent detection of rat parathyroid glands via 5-aminolevulinic acid. Laryngoscope 2008 0.81
65 Bone morphogenetic protein 6 expression in oral cavity squamous cell cancer is associated with bone invasion. Laryngoscope 2013 0.81
66 Increased likelihood of long-term gastrostomy tube dependence in head and neck cancer survivors without partners. Head Neck 2012 0.81
67 Evaluation of tyrosine receptor kinases in the interactions of head and neck squamous cell carcinoma cells and fibroblasts. Oral Oncol 2012 0.80
68 Functional outcomes following secondary free flap reconstruction of the head and neck. Laryngoscope 2009 0.80
69 Use of recombinant bone morphogenetic protein 2 in free flap reconstruction for osteonecrosis of the mandible. J Oral Maxillofac Surg 2011 0.80
70 Concern Reconstruction of scalp defects with the radial forearm free flap. Head Neck Oncol 2012 0.80
71 Barriers to early detection and treatment of head and neck squamous cell carcinoma in African American men. Head Neck 2009 0.80
72 Assessment of donor site morbidity for free radial forearm osteocutaneous flaps. Microsurgery 2012 0.80
73 Breast cancer imaging using the near-infrared fluorescent agent, CLR1502. Mol Imaging 2014 0.79
74 In vivo efficacy of marimastat and chemoradiation in head and neck cancer xenografts. ORL J Otorhinolaryngol Relat Spec 2008 0.79
75 CD147 expression in advanced cutaneous squamous cell carcinoma. J Cutan Pathol 2012 0.79
76 Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor. Laryngoscope 2012 0.79
77 Free flap reconstruction for osteoradionecrosis of the jaws--outcomes and predictive factors for success. Head Neck 2011 0.78
78 Free tissue transfer for head and neck reconstruction in solid organ transplant patients. Head Neck 2011 0.78
79 Postoperative reirradiation for mucosal head and neck squamous cell carcinomas. Arch Otolaryngol Head Neck Surg 2009 0.78
80 Phase 1 study of erlotinib plus radiation therapy in patients with advanced cutaneous squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2012 0.78
81 Outcomes of recurrent head and neck cutaneous squamous cell carcinoma. J Skin Cancer 2011 0.78
82 Hardware removal after osseous free flap reconstruction. Otolaryngol Head Neck Surg 2013 0.78
83 Microvascular anastomotic coupler assessment in head and neck reconstruction. Otolaryngol Head Neck Surg 2013 0.78
84 Parotid gland metastasis in Merkel cell carcinoma of the head and neck: A series of 14 cases. Ear Nose Throat J 2016 0.77
85 Mandibulectomy and free flap reconstruction for bisphosphonate-related osteonecrosis of the jaws. JAMA Otolaryngol Head Neck Surg 2013 0.77
86 Use of internal mammary vessels in head and neck microvascular reconstruction. Arch Otolaryngol Head Neck Surg 2012 0.77
87 Hemorrhage after transoral robotic-assisted surgery. Otolaryngol Head Neck Surg 2013 0.77
88 Time-dependent pretreatment with bevacuzimab increases tumor specific uptake of cetuximab in preclinical oral cavity cancer studies. Cancer Biol Ther 2015 0.77
89 Persistent posttreatment depressive symptoms in patients with head and neck cancer. Head Neck 2006 0.76
90 Three-dose vs extended-course clindamycin prophylaxis for free-flap reconstruction of the head and neck. Arch Otolaryngol Head Neck Surg 2003 0.76
91 Method for removing hypopharyngeal salivary bypass tubes. Laryngoscope 2011 0.76
92 Pulmonary atelectasis after reconstruction with a rectus abdominis free tissue transfer. Arch Otolaryngol Head Neck Surg 2002 0.75
93 Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection. Otolaryngol Head Neck Surg 2014 0.75
94 All-cause mortality after tracheostomy at a tertiary care hospital over a 10-month period. Otolaryngol Head Neck Surg 2012 0.75
95 Airway management after maxillectomy with free flap reconstruction. Head Neck 2012 0.75
96 Promotion of acellular dermal matrix resolution in vitro by matrix metalloproteinase-2. Arch Facial Plast Surg 2006 0.75
97 Reconstruction of periauricular and temporal bone defects. Facial Plast Surg Clin North Am 2009 0.75
98 Functional and survival outcomes in patients undergoing total glossectomy compared with total laryngoglossectomy. Otolaryngol Head Neck Surg 2011 0.75
99 Use of negative-pressure dressings to manage a difficult surgical neck wound. Ear Nose Throat J 2006 0.75
100 Software-Based Phase Control, Video-Rate Imaging, and Real-Time Mosaicing with a Lissajous-Scanned Confocal Microscope. IEEE Trans Med Imaging 2019 0.75